Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Net Cash Flow: 2010-2019

Historic Net Cash Flow for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Dec 2019 value amounting to -$27.7 million.

  • EyePoint Pharmaceuticals' Net Cash Flow rose 24.04% to -$27.7 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$49.0 million, marking a year-over-year decrease of 591.66%. This contributed to the annual value of -$181.6 million for FY2024, which is 197.81% down from last year.
  • As of Q4 2019, EyePoint Pharmaceuticals' Net Cash Flow stood at -$27.7 million, which was down 1,369.29% from -$1.9 million recorded in Q1 2019.
  • EyePoint Pharmaceuticals' 5-year Net Cash Flow high stood at $25.9 million for Q2 2018, and its period low was -$36.4 million during Q4 2018.
  • For the 3-year period, EyePoint Pharmaceuticals' Net Cash Flow averaged around -$1.8 million, with its median value being $1.1 million (2017).
  • Data for EyePoint Pharmaceuticals' Net Cash Flow shows a peak YoY increase of 544.17% (in 2018) and a maximum YoY decrease of 3,590.32% (in 2018) over the last 5 years.
  • EyePoint Pharmaceuticals' Net Cash Flow (Quarterly) stood at -$2.9 million in 2015, then rose by 8.77% to -$2.6 million in 2016, then surged by 139.79% to $1.0 million in 2017, then slumped by 3,590.32% to -$36.4 million in 2018, then rose by 24.04% to -$27.7 million in 2019.
  • Its Net Cash Flow was -$27.7 million in Q4 2019, compared to -$1.9 million in Q1 2019 and -$36.4 million in Q4 2018.